Boost Biotherapeutic Quality: Innovative Approaches to Sequence Variant Analysis

Join us for an insightful webinar to explore the critical impact of sequence variants on protein therapeutics and learn advanced methods for their detection and control.

What You’ll Learn:

• Impact of Variants: Discover how sequence variants in proteins can alter drug efficacy, stability, and trigger immune responses.
• Detection Techniques: Learn about icIEF-UV/MS workflows on the Intabio ZT system and EAD-enabled LC/MS methods on the ZenoTOF 7600 system for identifying challenging variants.
• Real-World Application: Dive into a case study where a cell and developability science team identified a previously uncharacterized sequence variant and developed a mitigation strategy.

Who Should Attend:

• Anyone Interested in Protein Therapeutics and Sequence Variants
• Biopharmaceutical Professionals (Scientists, Engineers, and Project Managers)
• Quality and Regulatory Specialists
• Analytical Chemists

Register now to stay ahead in biotherapeutic development and ensure your drug’s success.

All attendees will receive an attendance certificate.

Presenter: Kristen Nields (Principal Scientist, Johnson & Johnson Innovative Medicine)

Presenter: Riley Schaefer (Co-Op Scientist II, Johnson & Johnson Innovative Medicine)